Unauthorized and illegitimate production of medicines continues to jeopardize patient safety across the world. While regulators and manufacturers have made progress to secure global pharmaceutical supply chains, many of the packaging-based security approaches are ineffective.
In this case study, a coalition of technology partners demonstrates an effective and economic means of mass digitalizing medicines. The solution creates a secure link between the physical and digital world, delivering a level of supply-chain security and transparency not previously available to the pharmaceutical industry. The offering empowers patients in the verification process and illustrates how medicines can become trusted once more.
Complete the form to the right to get immediate access.